Clinical trials
Active, not recruiting Phase 3 trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
206 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 11 |
| 2019 | 11 |
| 2020 | 21 |
| 2021 | 34 |
| 2022 | 37 |
| 2023 | 41 |
| 2024 | 24 |
| 2025 | 12 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 206 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 44 |
| Novartis Pharmaceuticals | 26 |
| Eli Lilly and Company | 17 |
| Hoffmann-La Roche | 13 |
| Novo Nordisk A/S | 12 |
| Janssen Research & Development, LLC | 11 |
| Bristol-Myers Squibb | 8 |
| Pfizer | 8 |
| Sanofi | 5 |
| Amgen | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 24 |
| Breast Neoplasms | 21 |
| Neoplasm Metastasis | 9 |
| Lupus Erythematosus, Systemic | 7 |
| Multiple Myeloma | 6 |
| Recurrence | 6 |
| Renal Insufficiency, Chronic | 6 |
| Autoimmune Diseases | 5 |
| Carcinoma | 5 |
| Cardiovascular Diseases | 5 |
Trials
Showing 1 to 25 of 206. Each trial links to its page on Pharma Observatory.
106 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.